These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 15638783)

  • 1. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.
    Boyle JJ
    Curr Vasc Pharmacol; 2005 Jan; 3(1):63-8. PubMed ID: 15638783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms.
    Boyle JJ; Weissberg PL; Bennett MR
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1553-8. PubMed ID: 12869351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD70 limits atherosclerosis and promotes macrophage function.
    Winkels H; Meiler S; Smeets E; Lievens D; Engel D; Spitz C; Bürger C; Rinne P; Beckers L; Dandl A; Reim S; Ahmadsei M; Van den Bossche J; Holdt LM; Megens RT; Schmitt M; de Winther M; Biessen EA; Borst J; Faussner A; Weber C; Lutgens E; Gerdes N
    Thromb Haemost; 2017 Jan; 117(1):164-175. PubMed ID: 27786334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on acute coronary syndromes: the pathologists' view.
    Falk E; Nakano M; Bentzon JF; Finn AV; Virmani R
    Eur Heart J; 2013 Mar; 34(10):719-28. PubMed ID: 23242196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerosis as an inflammatory disease.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
    Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.
    Moreno PR; Falk E; Palacios IF; Newell JB; Fuster V; Fallon JT
    Circulation; 1994 Aug; 90(2):775-8. PubMed ID: 8044947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessing the Mechanisms of Acute Coronary Syndromes.
    Libby P; Pasterkamp G; Crea F; Jang IK
    Circ Res; 2019 Jan; 124(1):150-160. PubMed ID: 30605419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions.
    Boyle JJ; Bowyer DE; Weissberg PL; Bennett MR
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1402-7. PubMed ID: 11557663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 signaling in vascular cells: a key role in atherosclerosis?
    Mach F; Schönbeck U; Libby P
    Atherosclerosis; 1998 Apr; 137 Suppl():S89-95. PubMed ID: 9694547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques.
    Harmon EY; Fronhofer V; Keller RS; Feustel PJ; Zhu X; Xu H; Avram D; Jones DM; Nagarajan S; Lennartz MR
    J Am Heart Assoc; 2014 Dec; 3(6):e001232. PubMed ID: 25516435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective removal of macrophages in atherosclerotic plaques as a pharmacological approach for plaque stabilization: benefits versus potential complications.
    Croons V; Martinet W; De Meyer GR
    Curr Vasc Pharmacol; 2010 Jul; 8(4):495-508. PubMed ID: 19485918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
    Rosenson RS
    Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions.
    Boyle JJ; Weissberg PL; Bennett MR
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1624-30. PubMed ID: 12377740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis.
    Fenyo IM; Gafencu AV
    Immunobiology; 2013 Nov; 218(11):1376-84. PubMed ID: 23886694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
    Rudijanto A
    Acta Med Indones; 2007; 39(2):86-93. PubMed ID: 17933075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque.
    Libby P; Sukhova G; Lee RT; Galis ZS
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S9-12. PubMed ID: 8699871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.
    Blich M; Golan A; Arvatz G; Sebbag A; Shafat I; Sabo E; Cohen-Kaplan V; Petcherski S; Avniel-Polak S; Eitan A; Hammerman H; Aronson D; Axelman E; Ilan N; Nussbaum G; Vlodavsky I
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e56-65. PubMed ID: 23162016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.